Amanote Research
Register
Sign In
Erhaltungstherapie Mit Rituximab Reduziert Das Progressionsrisiko
Best Practice Onkologie
- Germany
doi 10.1007/bf03359727
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 1, 2010
Authors
Unknown
Publisher
Springer Science and Business Media LLC